Dana Alsaadi

521 total citations
6 papers, 389 citations indexed

About

Dana Alsaadi is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Dana Alsaadi has authored 6 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 2 papers in Epidemiology and 1 paper in Molecular Biology. Recurrent topics in Dana Alsaadi's work include Colorectal Cancer Treatments and Studies (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Microscopic Colitis (2 papers). Dana Alsaadi is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Microscopic Colitis (2 papers). Dana Alsaadi collaborates with scholars based in United States. Dana Alsaadi's co-authors include Aline Charabaty, Mark Mattar, Rohan Mandaliya, Maham Farshidpour, Nidhi Malhotra, David M. Richards, Hamzah Abu‐Sbeih, Faisal S. Ali, Yinghong Wang and Zimu Gong and has published in prestigious journals such as The American Journal of Gastroenterology, BMC Cancer and Journal for ImmunoTherapy of Cancer.

In The Last Decade

Dana Alsaadi

6 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dana Alsaadi United States	4	319	127	106	40	39	6	389
Emily Mao United States	3	329 1.0×	128 1.0×	90 0.8×	30 0.8×	18 0.5×	4	366
Jolanda van Dieren Netherlands	6	227 0.7×	81 0.6×	52 0.5×	60 1.5×	34 0.9×	11	307
Hajir Ibraheim United Kingdom	8	129 0.4×	102 0.8×	68 0.6×	46 1.1×	26 0.7×	26	259
Peter J. Bowling United States	5	255 0.8×	41 0.3×	163 1.5×	17 0.4×	6 0.2×	5	340
Haruhisa Machida Japan	8	63 0.2×	34 0.3×	85 0.8×	52 1.3×	19 0.5×	11	233
Ally Speight United Kingdom	7	63 0.2×	50 0.4×	31 0.3×	35 0.9×	18 0.5×	14	179
Joselyn Sanchez Peru	8	187 0.6×	27 0.2×	63 0.6×	48 1.2×	8 0.2×	14	269
Gaia Deleonardi Italy	11	46 0.1×	103 0.8×	42 0.4×	40 1.0×	21 0.5×	20	252
Ignatius Chua United Kingdom	8	60 0.2×	55 0.4×	202 1.9×	27 0.7×	8 0.2×	13	288
Masanori Kadowaki Japan	7	61 0.2×	23 0.2×	84 0.8×	17 0.4×	18 0.5×	20	227

Countries citing papers authored by Dana Alsaadi

Since Specialization

Citations

This map shows the geographic impact of Dana Alsaadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Alsaadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Alsaadi more than expected).

Fields of papers citing papers by Dana Alsaadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Alsaadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Alsaadi. The network helps show where Dana Alsaadi may publish in the future.

Co-authorship network of co-authors of Dana Alsaadi

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Alsaadi. A scholar is included among the top collaborators of Dana Alsaadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Alsaadi. Dana Alsaadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Li, Yichao, Sushil Kumar Jaiswal, Dana Alsaadi, et al.. (2021). Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer. BMC Cancer. 21(1). 768–768. 10 indexed citations

2.

Mandaliya, Rohan, Dana Alsaadi, Maham Farshidpour, et al.. (2021). A Comprehensive Review on Immune Checkpoint Inhibitor-induced Colitis. Book Publisher International (a part of SCIENCEDOMAIN International). 59–76. 1 indexed citations

3.

Alsaadi, Dana, Neil J. Shah, Aline Charabaty, & Michael B. Atkins. (2019). A case of checkpoint inhibitor-induced celiac disease. Journal for ImmunoTherapy of Cancer. 7(1). 203–203. 29 indexed citations

4.

Mandaliya, Rohan, Dana Alsaadi, Maham Farshidpour, et al.. (2019). Immune checkpoint inhibitor-induced colitis: A comprehensive review. World Journal of Clinical Cases. 7(4). 405–418. 185 indexed citations

5.

Abu‐Sbeih, Hamzah, Faisal S. Ali, Dana Alsaadi, et al.. (2018). Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study. Journal for ImmunoTherapy of Cancer. 6(1). 142–142. 163 indexed citations

6.

Abu‐Sbeih, Hamzah, Faisal S. Ali, Dana Alsaadi, et al.. (2018). Outcomes of Vedolizumab Treatment in Patients With Immune Checkpoint Inhibitor-Induced Diarrhea and Colitis: A Multi-Center Study. The American Journal of Gastroenterology. 113(Supplement). S58–S58. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact